Get in touch

Tiefenbacher Group: Renovating Headquarters in Hamburg

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group: Renovating Headquarters in Hamburg /Germany – an agile, open-plan work spaceTiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while maintaining the importance of the office as a place for collaboration and personal interaction. Did you know that Tiefenbacher Group is currently renovating its headquarters in Hamburg, Germany as a response […]

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

Tiefenbacher Group - OYSTA logo beside a medical device showing "10 mg" and a smartphone displaying the OYSTA app for mood tracking, dosage management, and health logs—highlighting patient-centric drug development in pharmaceutical healthcare solutions.

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation medicine. The idea is to improve the health and everyday lives of millions of patients by giving […]

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop and commercialize innovative products within individualized treatments and digital health, combining traditional drug-based medicines with digital therapeutics and intelligent dosing. TIEFENBACHER GROUP and OnDosis enter a […]

Get in touch